SCHEMBL10679043

SCHEMBL10679043

Cc1[nH]c(-c2cccnc2)nc1C(=O)CBr

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 4/20 0.50
NPY5R Q15761 3/20 0.50
KMT2A Q03164 1/20 0.49
HCRTR1 O43613 1/20 0.48
PKN1 Q16512 1/20 0.43
PKN2 Q16513 1/20 0.43
HPGD P15428 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LDHA P00338 1/20 0.43
EPHX2 P34913 1/20 0.43
MMP2 P08253 1/20 0.42
MMP13 P45452 1/20 0.42
MMP14 P50281 1/20 0.42
MAPT P10636 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
DHODH Q02127 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10937354 0.88 PIN1 (0.51) PIN1NPY5RKMT2AHCRTR1PKN1
SCHEMBL10939665 0.86 NPY5R (0.49) PIN1NPY5RKMT2AHCRTR1PKN1
SCHEMBL8963968 0.85 PIN1 (0.69) PIN1KDM4EMAPT
SCHEMBL10938042 0.85 NPY5R (0.48) PIN1NPY5RKMT2AHCRTR1PKN1
SCHEMBL10938799 0.84 NPY5R (0.47) PIN1NPY5RKMT2AHCRTR1PKN1
SCHEMBL10679369 0.83 PIN1 (0.55) PIN1NPY5RKMT2AHCRTR1PKN1
SCHEMBL10649656 0.83 PIN1 (0.72) PIN1NPY5RKMT2AHCRTR1PKN1
SCHEMBL10940084 0.83 FAAH (0.47) PIN1NPY5RKMT2AHCRTR1HPGD
SCHEMBL3418983 0.82 NPY5R (0.50) PIN1NPY5RKMT2AHCRTR1PKN1
SCHEMBL8963720 0.80 PIN1 (0.71) PIN1HCRTR1HPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4732895-A α-[5-methyl-2-(pyridinyl)-1H-imidazol-4-yl]substituted-1-piperazineethanols useful for treating hypertension AMERICAN CYANAMID COMPANY (US) 1988-03-22 US disclosed